Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4842861

COC(=O)c1cc(CNc2ccc(-c3nc4cc(Br)cnc4[nH]3)cc2)cn1C.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPSE Q9Y251 5/20 0.38
MMP2 P08253 2/20 0.36
MMP9 P14780 2/20 0.36
MMP8 P22894 2/20 0.36
MMP13 P45452 2/20 0.36
ABL1 P00519 6/20 0.34
SRC P12931 3/20 0.34
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRB2 P47870 1/20 0.33
GABRA4 P48169 1/20 0.33
GABRE P78334 1/20 0.33
GABRA6 Q16445 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4844738 0.94 HPSE (0.41) HPSEMMP2MMP9MMP8MMP13
SCHEMBL5261764 0.87 HPSE (0.39) HPSEMMP2MMP9MMP8MMP13
Trifluoroacetic Acid SCHEMBL4837278 0.84 HPSE (0.45) HPSEGAA
Trifluoroacetic Acid SCHEMBL4844163 0.82 HIF1A (0.46) HPSEMMP13
Trifluoroacetic Acid SCHEMBL4840394 0.82 SYK (0.35) HPSEMMP2MMP9MMP8MMP13
SCHEMBL5262858 0.82 HPSE (0.40) HPSEMMP2MMP9MMP8MMP13
Trifluoroacetic Acid SCHEMBL4845670 0.81 FFAR1 (0.42) HPSE
Trifluoroacetic Acid SCHEMBL4844134 0.81 HPSE (0.36) HPSEMMP2MMP9MMP8MMP13
Trifluoroacetic Acid SCHEMBL4844349 0.80 HPSE (0.36) HPSEMMP2MMP9MMP8MMP13
Trifluoroacetic Acid SCHEMBL4842251 0.80 TPH1 (0.37) HPSEMMP2MMP9MMP8MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 HPSE 4318/4885MMP2 3540/4885MMP9 4224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.